Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19-Reference-Cited by-同舟云学术

Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19

Published:2021-09-06 Issue: Volume:8 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Alape-Girón Alberto,Moreira-Soto Andrés,Arguedas Mauricio,Brenes Hebleen,Buján Willem,Corrales-Aguilar Eugenia,Díaz Cecilia,Echeverri Ann,Flores-Díaz Marietta,Gómez Aarón,Hernández Andrés,Herrera María,León Guillermo,Macaya Román,Molina-Mora José Arturo,Mora Javier,Narayanan Aarthi,Sanabria Alfredo,Sánchez Andrés,Sánchez Laura,Segura Álvaro,Segura Eduardo,Solano Daniela,Soto Claudio,Stynoski Jennifer L.,Vargas Mariángela,Villalta Mauren,Drexler Jan Felix,Gutiérrez José María

Funder

Vicerrectoría de Investigación, Universidad de Costa Rica

Publisher

Frontiers Media SA

Subject

General Medicine

Reference40 articles.

1. COVID-19 pandemic and equal access to vaccines;Bolcato;Vaccines,2021

2. COVID-19 therapeutics for low- and middle-income countries: a review of candidate agents with potential for near-term use and impact;Maxwell;Am J Trop Med Hyg,2021

3. SARS-CoV-2 variants, spike mutations and immune escape;Harvey;Nat Rev Microbiol,2021

4. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil;Goes;Infect Genet Evol,2021

5. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis;Mair-Jenkins;J Infect Dis,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study;Clinical Pharmacokinetics;2024-03-01

2. Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study;2023-03-09

3. Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep;2022-12-12

4. Therapeutic monoclonal antibodies for COVID-19 management: an update;Expert Opinion on Biological Therapy;2022-05-29

5. Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants;Clinical Immunology;2022-04